Dis-Chem Grapples with Retail Squeeze and Fierce Competition
The group identifies limited availability of profitable locations as a key risk to its expansion strategy, which relies on opening new stores and acquiring independent pharmacies.
Competition Commission probes insulin price fixing
The Competition Commission is investigating insulin manufacturers Novo Nordisk and Sanofi Aventis, raising concerns about accessibility to diabetes care.